GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $57,000 | +147.8% | 6,327 | +22.2% | 0.00% | – |
| Q2 2016 | $23,000 | -11.5% | 5,176 | 0.0% | 0.00% | – |
| Q1 2016 | $26,000 | -33.3% | 5,176 | 0.0% | 0.00% | – |
| Q4 2015 | $39,000 | -22.0% | 5,176 | -23.8% | 0.00% | – |
| Q3 2015 | $50,000 | +31.6% | 6,793 | +76.4% | 0.00% | – |
| Q2 2015 | $38,000 | – | 3,850 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 202,100 | $2,318,000 | 1.99% |
| Gerry Farber, LLC | 52,000 | $596,000 | 1.03% |
| Granite Point Capital Management, L.P. | 115,000 | $1,319,000 | 0.94% |
| 683 Capital Management, LLC | 158,735 | $1,821,000 | 0.71% |
| SPHERA FUNDS MANAGEMENT LTD. | 170,000 | $1,950,000 | 0.44% |
| Knoll Capital Management, LLC | 65,000 | $746,000 | 0.39% |
| Healthcare Value Capital, LLC | 50,000 | $574,000 | 0.38% |
| Park West Asset Management LLC | 200,000 | $2,294,000 | 0.26% |
| Perceptive Advisors | 75,000 | $860,000 | 0.09% |
| HIGHLAND CAPITAL MANAGEMENT LP | 126,956 | $1,456,000 | 0.06% |